We are live on
!
Find out more
GP
GLG Partners Portfolio holdings
AUM
$2.14B
1-Year Est. Return
21.14%
This Fund
S&P 500
This Quarter
Est. Return
+5.92%
1 Year Est. Return
+21.14%
3 Year Est. Return
+49.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.43B
AUM Growth
-$936M
(-21%)
Cap. Flow
-$1.57B
Cap. Flow
% of AUM
-45.64%
Top 10 Holdings %
Top 10 Hldgs %
19.04%
Holding
546
New
124
Increased
63
Reduced
108
Closed
158
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
+$59.7M |
| 2 |
HCT
AMRICAN RLTY CAP HEALTHCARE TRUST INC. COMMON STOCK
HCT
|
+$51.2M |
| 3 |
TRW
TRW AUTOMOTIVE HOLDINGS CORP
TRW
|
+$50.2M |
| 4 |
Cardinal Health
CAH
|
+$40.5M |
| 5 |
AGN
Allergan Inc
AGN
|
+$34.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$71.2M |
| 2 |
McKesson
MCK
|
+$61.3M |
| 3 |
Methanex
MEOH
|
+$45.9M |
| 4 |
APC
Anadarko Petroleum
APC
|
+$43.6M |
| 5 |
Revvity
RVTY
|
+$38.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.29% |
| 2 | Consumer Discretionary | 7.94% |
| 3 | Technology | 7.1% |
| 4 | Financials | 5.32% |
| 5 | Industrials | 5.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSOD
101
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $6.27M | 0.18% |
178,035
+62,956
| +55% | +$2.08M |
|
102
iShares Biotechnology ETF
IBB
$9.31B
| $6.26M | 0.18% |
61,929
-17,067
| -22% | -$1.66M |
|
103
Blackstone
BX
$104B
| $6.23M | 0.18% |
+187,530
| New | +$5.87M |
|
|
SPR
104
DELISTED
Spirit AeroSystems
SPR
| $6.14M | 0.18% |
+142,613
| New | +$5.77M |
|
|
BEAV
105
DELISTED
B/E Aerospace Inc
BEAV
| $6.12M | 0.18% |
+105,466
| New | +$5.88M |
|
|
PCP
106
DELISTED
PRECISION CASTPARTS CORP
PCP
| $6.05M | 0.18% |
+25,113
| New | +$5.8M |
|
107
Alibaba
BABA
$269B
| $6.02M | 0.18% |
57,898
-2,702
| -4% | -$277K |
|
108
Freeport-McMoran
FCX
$90B
| $5.96M | 0.17% |
255,279
-248,768
| -49% | -$6.87M |
|
|
ANDV
109
DELISTED
Andeavor
ANDV
| $5.87M | 0.17% |
78,973
-209,290
| -73% | -$14.8M |
|
110
Best Buy
BBY
$18B
| $5.68M | 0.17% |
145,667
+100,502
| +223% | +$3.53M |
|
111
Halliburton
HAL
$27.9B
| $5.64M | 0.16% |
143,465
-128,858
| -47% | -$6.27M |
|
112
Merck
MRK
$324B
| $5.49M | 0.16% |
101,241
+99,445
| +5,537% | +$5.54M |
|
113
Gilead Sciences
GILD
$161B
| $5.45M | 0.16% |
+57,784
| New | +$5.98M |
|
114
CALL
AT&T
T
$165B
| $5.37M | 0.16% |
+211,840
| New | +$5.5M |
|
|
RTN
115
DELISTED
Raytheon Company
RTN
| $5.36M | 0.16% |
49,533
+12,252
| +33% | +$1.26M |
|
116
Hudbay
HBM
$9.92B
| $5.34M | 0.16% |
611,238
+147,056
| +32% | +$1.15M |
|
|
ZAIS
117
DELISTED
ZAIS Group Holdings, Inc.
ZAIS
| $5.21M | 0.15% |
500,000
| – | – |
|
|
CFN
118
DELISTED
CAREFUSION CORPORATION
CFN
| $5.2M | 0.15% |
+87,683
| New | +$5.04M |
|
119
CALL
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.42B
| $5.13M | 0.15% |
+26,800
| New | +$5.96M |
|
|
SEMG
120
DELISTED
SEMGROUP CORPORATION
SEMG
| $5.08M | 0.15% |
74,347
+10,438
| +16% | +$770K |
|
121
Lindblad Expeditions
LIND
$1.76B
| $4.94M | 0.14% |
500,000
| – | – |
|
|
CELG
122
DELISTED
Celgene Corp
CELG
| $4.9M | 0.14% |
43,795
-29,552
| -40% | -$3.12M |
|
123
Scorpio Tankers
STNG
$3.96B
| $4.87M | 0.14% |
56,052
+51,045
| +1,019% | +$4.23M |
|
|
TRTL
124
DELISTED
Terrapin 3 Acquisition Corporation Class A
TRTL
| $4.85M | 0.14% |
+500,000
| New | +$4.8M |
|
|
EMBJ
125
Embraer S.A. ADS
EMBJ
$11.6B
| $4.83M | 0.14% |
+131,012
| New | +$4.82M |
|
Similar funds
IH
GL
TAM
SI
GES
AS
QAM
BTIS
GLG Partners's Q4 2014 Portfolio in Review
As of Q4 2014, GLG Partners held 546 positions worth $3.43B, down 21% from $4.37B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
GLG Partners withdrew a net $1.57B in Q4 2014, closing 158 positions and reducing 108 holdings. Its most notable exit was Methanex, an estimated $45.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, GLG Partners opened a new position in CUBIST PHARMACEUTICALS INC worth $77.3M.
- GLG Partners's largest Q4 2014 buy was CUBIST PHARMACEUTICALS INC: 767,613 shares worth $77.3M.
- GLG Partners added most to TRW AUTOMOTIVE HOLDINGS CORP in Q4 2014, an estimated $50.2M increase.
- GLG Partners's biggest Q4 2014 reduction was COVIDIEN PLC COM SHS NEW (IRELAND), cutting an estimated $71.2M.
- GLG Partners fully exited Methanex in Q4 2014, selling an estimated $45.9M.
- GLG Partners's ten largest holdings make up 19% of its $3.43B portfolio in Q4 2014.
- GLG Partners opened 124 new positions and closed 158 in Q4 2014.
- GLG Partners's portfolio value fell 21% quarter-over-quarter to $3.43B.
Based on GLG Partners's 13F filing for Q4 2014, filed 17 Feb 2015.